• Sun. Sep 20th, 2020

Biotech

  • Home
  • San Diego’s Sorrento Therapeutics May Be First Viable Vaccine for COVID-19

San Diego’s Sorrento Therapeutics May Be First Viable Vaccine for COVID-19

San Diego-based Sorrento Therapeutics recently announced that its anti-SARS-CoV-2 antibody, STI-1499, demonstrated 100% inhibition of SARS-CoV-2 virus infection in an in vitro virus infection experiment at a very low antibody concentration. As…

Forge Therapeutics Wins Powered by CARB-X Research Award of $8.8M

San Diego-based Forge Therapeutics, Inc., a biotechnology company discovering first-in-class antibiotics using a breakthrough drug discovery platform, recently announced a significant collaboration with CARB-X, (Combating Antibiotic Resistant Bacteria Accelerator), the…